.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AB11_TaligluceraseAlfa.TaligluceraseAlfa .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AB11_TaligluceraseAlfa.TaligluceraseAlfa| name: | TaligluceraseAlfa | |
| ATC code: | A16AB11 | |
| route: | intravenous | |
| compartments: | 2 | |
| dosage: | 30 | mg |
| volume of distribution: | 5.06 | L |
| clearance: | 16.2 | L/h |
| other parameters in model implementation | ||
Taliglucerase alfa is a recombinant enzyme replacement therapy used for the treatment of Gaucher disease type 1. It is a form of the human enzyme beta-glucocerebrosidase produced in carrot cells, and is approved for clinical use in several countries.
Pharmacokinetics reported in adult and pediatric patients with Gaucher disease type 1 following intravenous infusion.